Certain Birth Control Pills, Devices Linked to Higher Heart Risks

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 13, 2025.

By Ernie Mundell HealthDay Reporter

THURSDAY, Feb. 13, 2025 -- The most common formulation of birth control pills has been linked to a doubling of relative risk of heart attack and stroke, a new study finds.

Contraceptive vaginal rings and skin patches formulated in the same way were also linked to higher heart risks.

Danish researchers stressed that the absolute risk to any one woman using these pills, patches or rings remains very low.

However, they said the findings are something for doctors to think about as they prescribe contraceptives.

The pill formulation in question is a combination of the hormones estrogen plus progestin, the team reported Feb. 12 in The BMJ.

It's the most-prescribed type of hormonal contraception.

“Although absolute risks were low, clinicians should include the potential risk of arterial thrombosis [blood clots] in their assessment of the benefits and risks when prescribing hormonal contraceptive method," wrote researchers led by Dr. Harman Yonis. He's with the Department of Cardiology at Nordsjaellands Hospital in Hilleroed, Denmark.

According to the research team, an estimated 250 million women worldwide are thought to use some form of hormonal contraception. Prior research has linked this form of birth control to heightened cardiovascular risk, but findings have varied study-to-study.

The new study involved a deep dive into national prescription records for more than 2 million Danish women, who were tracked from 1996 through 2021. They ranged in age from 15 to 49.

Contraceptives included estrogen-progestin pills, vaginal rings, patches, progestin-only pills, intrauterine devices (IUDs), under-the-skin implants and intramuscular injections.

Yonis' team compared the use of each woman's contraceptive of choice (or no use) against their history (if any) of first-time heart attack and ischemic stroke. (Ischemic strokes, the most common form of stroke, are caused when a clot blocks a vessel supplying blood to the brain).

The study did not include women who'd already experienced a blood clot, or those with cancer, liver disease, kidney disease, polycystic ovary syndrome, endometriosis or infertility treatment; as well as those who used psychiatric medications or hormone therapy, or who had undergone a hysterectomy.

After accounting for factors such as age, education level and existing conditions such as high blood pressure and diabetes, the team found that women taking the combo estrogen/progestin pill had double the relative risk of an ischemic stroke or heart attack.

However, each woman's absolute risk remained low: Use of the estrogen/progestin pill translated to one extra stroke for every 4,760 women using the pill for one year, and one extra heart attack for every 10,000 women per year of use, the researchers noted.

Pills and implants that contained progestin only also raised a woman's risk for stroke and heart attack, but only slightly and less than the combination pill.

The risk was highest for vaginal rings and skin patches containing the estrogen/progestin combination. These devices raised a woman's risk for ischemic stroke by 2.4-fold and heart attack by 3.8-fold, the team found.

Dual-hormone skin patch contraceptives increased ischemic stroke risk by 3.4-fold, according to the study.

Only one form of hormonal contraception showed no rise in cardiovascular risk: The progestin-only IUD, which seemed safe even over an extended period of use.

Yonis' team stressed that the study was observational in nature, meaning it was not designed to prove that any of the contraceptives caused a rise in heart risks. It could only point to associations.

In a linked journal editorial, Therese Johansson, of the Swedish Institute of Technology, stressed that the risk to any one user of hormonal contraceptives remains very low. However, since hundreds of millions of women worldwide use these pills and devices, the study findings remain important.

Any effort to improve the safety of contraception is therefore welcome, Johannson said.

Sources

  • The BMJ, news release, Feb. 12, 2025

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2025-02-14 00:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords